Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: EyeDrMike who wrote (1175)	4/16/1998 12:09:00 AM
From: John Chatterton	Respond to of 9523

It makes you go blind? Does it also grow hair on your palms? Seriously, maybe this is the reason for the blue vision some people report.

To: EyeDrMike who wrote (1175)	4/16/1998 1:16:00 AM
From: BigKNY3	Read Replies (2) \| Respond to of 9523

Eye: If you believed your research, why are you posting it to an investment board? Send it quick to the FDA...without delay! By the way, the FDA has already extensively reviewed abnormal vision and Viagra. In 21 clinical studies of over 3,700 patients (550 patients treated for more than one year), exactly one patient discontinued therapy due to abnormal vision. Click here to read the approved Viagra labeling viagra.com or click here to read information from the FDA Viagra Website. fda.gov Following the Pfizer submission in September, 1997, the FDA gave Viagra an expedited priority NDA review and did not require a FDA panel committee review. The FDA reviewers remarked that the size of the Viagra clinical trials "comparable to the typical database for a new antihypertensive agent" added comfort to their approval decision. Have PFun! BigKNY3 PS You should be embarrassed for the header to your post! It makes me wonder whether investing in VVUS causes depression and induces poor judgment.